Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
698387-09-6
Purity
95%
Neratinib is a tyrosine kinase inhibitor which exhibits antitumor action against Epidermal Growth Factor Receptor, HER2, and Human Epidermal Growth Factor Receptor 4 (HER4) postive carcinomas. It is used to treat breast cancer that over expresses the HER2 receptor.
Properties
Name
Neratinib
Smiles
CCOC=1C=C2N=CC(C#N)=C(NC=3C=CC(OCC=4C=CC=CN4)=C(Cl)C3)C2=CC1NC(=O)/C=C/CN(C)C
Targets
Please log in to see this information
SDS
HKI-272 | neratinib | nerlynx
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$37
2 mg
$39
5 mg
$41
10 mg
$43
15 mg
$45
20 mg
$48
25 mg
$53
30 mg
$56
35 mg
$59
40 mg
$61
45 mg
$64
50 mg
$66
75 mg
$69
100 mg
$POA
Quantity
1
Total amount
$ 41
HKI-272 | neratinib | nerlynx
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:915942-22-2
0
CAS:698387-09-6
0